[1] 佟印妮, 郑吉敏. 功能性便秘诊断技术的进展[J]. 临床荟萃, 2020, 35(6): 573-576.
[2] 翟振武, 陈佳鞠, 李龙. 中国人口老龄化的大趋势、新特点及相应养老政策[J]. 山东大学学报(哲学社会科学版), 2016(3): 27-35.
[3] 刘晓红, 朱鸣雷. 老年人疾病特点与老年医学的干预策略[J]. 中华临床医师杂志:电子版, 2013,7(2): 458-459.
[4] 李振, 钟世彪, 农建政. 中医药治疗慢性功能性便秘进展[J]. 中国处方药, 2021, 19(6): 17-19.
[5] 中华医学会消化病学分会胃肠动力学组,中华医学会外科学分会结直肠肛门外科学组.中国慢性便秘诊治指南(2013,武汉)[J]. 胃肠病学, 2013, 18(10): 605-612.
[6] AZIZ I, PALSSON O S, TORNBLOM H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study[J]. Lancet Gastroenterol hepatol, 2018,3(4):252-262.
[7] KAMIYA T, OSAGA S, KUBOTA E, et al. Questionnaire-based survey on epidemiology of functional gastrointestinal disorders and current status of gastrointestinal motility testing in Asian countries[J]. Digestion, 2020, 102(1): 73-89.
[8] GHOSHAL U C, SACHDEVA S, PRATAP N, et al. Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology[J]. Indian J Gastroenterol, 2018, 37(6): 526-544.
[9] 杨直, 吴晨曦, 高静, 等. 中国成年人慢性便秘患病率的Meta分析[J]. 中国全科医学, 2021, 24(16): 2092-2097.
[10] 姚健凤, 郑松柏. 老年人慢性便秘的评估与处理专家共识解读[J]. 中华老年病研究电子杂志, 2017, 4(2): 28-31.
[11] 郭晓峰, 柯美云, 潘国宗,等. 北京地区成人慢性便秘整群、分层、随机流行病学调查及其相关因素分析[J]. 中华消化杂志, 2002, 22(10): 637-638.
[12] BLACK C J, FORD A C. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management[J]. Med J Aust, 2018, 209(2): 86-91.
[13] CHU H, ZHONG L, LI H, et al. Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in china[J].Gastroenterol Res Pract, 2014,2014:532734.
[14] 向国春, 龙庆林, 刘利,等. 重庆市人群便秘患病率流行病学研究[J]. 重庆医学, 2004, 33(10): 1541,1543.
[15] 熊理守, 陈旻湖, 陈惠新, 等. 广东省社区人群慢性便秘的流行病学研究[J]. 中华消化杂志, 2004,248(8): 488-491.
[16] OH J H, KWON J G, JUNG H K, et al. Clinical practice guidelines for functional dyspepsia in Korea[J]. J Neurogastroenterol Motil, 2020, 26(1): 29-50.
[17] PARE P, FERRAZZI S, THOMPSON W G, et al. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking[J]. Am J Gastroenterol, 2001, 96(11): 3130-3137.
[18] 王薇, 许乐, 邱蕾. 中国老年人便秘评估技术应用共识(草案)[J]. 中国老年保健医学, 2019, 17(4): 46-47.
[19] SUMIDA K, MOLNAR M Z, POTUKUCHI P K, et al. Constipation and risk of death and cardiovascular events[J]. Atherosclerosis, 2019, 281:114-120.
[20] 朱丽明, 方秀才, 刘诗,等. 全国多中心慢性便秘患者情绪和睡眠状况的调查[J]. 中华医学杂志, 2012,92(32): 2243-2246.
[21] AZIZ I, WHITEHEAD W E, PALSSON O S, et al. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation[J].Expert Rev Gastroenterol Hepatol, 2020, 14(1): 39-46.
[22] 蓝海波, 魏雨, 甘华田,等. 《2017版便秘的分度与临床策略专家共识》解读[J]. 结直肠肛门外科, 2020, 26(3): 257-259.
[23] ANTI M, PIGNATARO G, ARMUZZI A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation[J]. Hepatogastroenterology, 1998, 45(21): 727-732.
[24] GAO R, TAO Y,ZHOU C,et al. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials[J]. Scand J Gastroenterol, 2019, 54(2): 169-177.
[25] CAMILLERI M, PIESSEVAUX H, YIANNAKOU Y, et al. Efficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trials[J]. Dig Dis Sci, 2016, 61(8): 2357-72.
[26] KNOWLES C H, GROSSI U, CHAPMAN M, et al. Surgery for constipation: systematic review and practice recommendations: Results I: Colonic resection[J]. Colorectal Dis, 2017, 19 Suppl 3:17-36.
[27] TACK J, M LLER-LISSNER S, STANGHELLINI V, et al. Diagnosis and treatment of chronic constipation--a European perspective[J].Neurogastroenterol Motil, 2011, 23(8): 697-710.
[28] 余跃, 吴德卫. 老年人慢性便秘治疗药物的选择[J]. 中国临床保健杂志, 2019, 22(1): 10-14.
[29] RAO S S C, VALESTIN J A, XIANG X, et al. Home-based versus office-based biofeedback therapy for constipation with dyssynergic defecation: a randomised controlled trial[J].Lancet Gastroenterol hepatol, 2018, 3(11): 768-777.
[30] RAO S S C, GO J T, VALESTIN J, et al. Homebiofeedback for the treatment of dyssynergic defecation: does it improve quality of life and is it cost-effective?[J]. Am J Gastroenterol, 2019, 114(6): 938-944.
[31] PATTON V, STEWART P, LUBOWSKI D Z, et al. Sacral nerve stimulation fails to offer long-term benefit in patients with slow-transit constipation[J]. Dis Colon Rectum, 2016, 59(9): 878-885. |
